CarcinEx

CarcinEx is a biotechnology company specializing in the development of advanced 3D microfluidic "tumor-on-a-chip" technology for oncology drug discovery. The company's platform is designed to replicate the complex human tumor microenvironment, including the interaction between cancer cells, stromal cells, and the vascular system. By providing a more physiologically relevant model than traditional 2D cultures, CarcinEx enables researchers to better predict drug efficacy and toxicity in humans. The technology supports high-throughput screening and real-time monitoring, allowing for the rapid evaluation of various therapeutic modalities such as small molecules and immunotherapies. CarcinEx aims to reduce the high failure rates in clinical trials by identifying the most promising drug candidates during the preclinical phase. In addition to platform sales, the company offers contract research services to pharmaceutical and biotechnology partners seeking to optimize their oncology pipelines.